Ambev S.A. Files 6-K Report

Ticker: ABEV · Form: 6-K · Filed: Dec 10, 2024 · CIK: 1565025

Ambev S.A. 6-K Filing Summary
FieldDetail
CompanyAmbev S.A. (ABEV)
Form Type6-K
Filed DateDec 10, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, filing-update

TL;DR

Ambev S.A. filed a standard 6-K, no major news.

AI Summary

Ambev S.A. filed a Form 6-K on December 10, 2024, for the reporting period ending December 31, 2024. This filing is a report of a foreign private issuer and does not indicate any specific financial transactions or events.

Why It Matters

This filing serves as a routine update for investors and the SEC regarding Ambev S.A.'s status as a foreign private issuer, providing transparency on its reporting obligations.

Risk Assessment

Risk Level: low — This is a routine filing by a foreign private issuer and does not contain specific financial disclosures or material events.

Key Players & Entities

FAQ

What type of filing is this for Ambev S.A.?

This is a Form 6-K, a Report of Foreign Private Issuer.

When was this Form 6-K filed?

The filing date was December 10, 2024.

What is the reporting period for this filing?

The conformed period of report is December 31, 2024.

Does Ambev S.A. file annual reports under Form 20-F or 40-F?

Ambev S.A. files annual reports under Form 20-F.

Is Ambev S.A. furnishing information to the Commission pursuant to Rule 12g3-2(b)?

No, Ambev S.A. is not furnishing information pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Filing Stats: 398 words · 2 min read · ~1 pages · Grade level 12.3 · Accepted 2024-12-10 16:01:09

Filing Documents

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of December, 2024 Commission File Number 1565025 AMBEV S.A. (Exact name of registrant as specified in its charter) AMBEV S.A. (Translation of Registrant's name into English) Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor 04530-000 São Paulo, SP Federative Republic of Brazil (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ___X___ Form 40-F _______ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes _______ No ___X____ INDIVIDUAL FORM Article 11 - CVM Instruction # 358/2002 In November 2024: (X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1) ( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows. Company Name: Ambev S.A. Name: Ambev S.A. CPF/CNPJ: 07.526.557/0001-00 Qualification: Outstanding Shares in Treasury Initial Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 29,443,171 ADR Common 0,00 Transactions in the month Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3) Shares Common Direct with the Company Delivery Restricted Shares 02 22,080 12.54 276,883.20 Final Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 29,421,091 ADR Common 0,00 (1) When filling in the form, delete the lines that do not have any information, If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information, (2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others, (3) Quantity multiplied by price, (*) Each ADR is equivalent to 1 (one) share, SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: December 10, 2024 AMBEV S.A. By: /s/ Lucas Machado Lira Lucas Machado Lira Chief Financial and Investor Relations Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing